We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Dr Buesa (BSc Biol Sc.) got his PhD in Mol. Biology from the Univ. of Barcelona, Spain. He was a EU post-doctoral fellow in the Faculty of Medicine at the Univ. of Ghent in Belgium and later Senior Investigator at the Flemish Institute of Biotechnology (VIB). He has also taken the executive PADE programme at IESE Business School and several other additional programs in finances. In 2000, he founded Oryzon, and since inception, he has been CEO and Chairman. Under his leadership the company has got +65M € in several equity funding rounds +70 M € in non dilutive funds. After a transforming partnering deal with Roche in 2014, Dr Buesa leaded Oryzon to become a public company in 2015 in the Madrid Main Stock exchange. In 1Q2017 he led a successful 18.2M€ Pipes ($20m) offering that included institutional investors specialized in healthcare and life sciences from the US, Spain and rest of Europe, In 2018 he led an additional 13M€ Pipe further reinforcing and diversifying the shareholder base
This speaker's sessions: